X4 Pharmaceuticals, Inc(XFOR)Earnings Date, History & Expected Move
Next report date, beat rate and options-implied move
XFOR has no upcoming report date in the calendar yet. It last reported on Nov 4, 2026; companies usually report every three months.
EPS: Actual vs Estimate
Reported EPS against the consensus estimate, last 12 quarters.
Green beat or met, red missed, amber sources differ.
Stock Reaction After Earnings
Close-to-close move in the first session that reflected each report.
Dashed lines mark the average actual move (±14.5%).
Did the stock rise after good news?
The next-day move after each of its last 8 EPS beats and 4 misses.
In plain words: it beat expectations 8 times, but the stock still fell 4 of those 8 times.
- Nov '26Beat▼ -5.2%
- Aug '26Beat▲ +11.3%
- May '26Beat▲ +4.3%
- Mar '26Beat▲ +18.8%
- Nov '25Beat▼ -10.6%
- Aug '25Beat▼ -4.7%
- May '25Beat▼ -13.0%
- Mar '25Missed▼ -12.2%
- Nov '24Missed▼ -53.2%
- Aug '24Missed▲ +3.3%
- May '24Missed▼ -9.2%
- Mar '24Beat▲ +28.4%
Clear beats and misses with a known reaction only. What counts as a beat
Why did XFOR fall after beating earnings?
5 of XFOR's last 12 reactions went against the EPS result. What stands out in each:
XFOR beat EPS estimates in 8 quarters, and the stock still closed lower the next day 4 times. In 2 of the 4 where we have price data, the stock had already run up before the report.
- Nov 4, 2026EPS beat +15.8%stock -5.2% next day
- It had risen 15.3% in the 20 trading sessions before the report, so good news may already have been priced in.
- It opened 5.2% lower as soon as trading resumed.
- Nov 5, 2025EPS beat +17.9%stock -10.6% next day
- It had risen 15.4% in the 20 trading sessions before the report, so good news may already have been priced in.
- It opened 6.3% lower as soon as trading resumed.
- Aug 8, 2025EPS beat +20.0%stock -4.7% next day
- It opened 1.3% lower as soon as trading resumed.
- May 1, 2025EPS beat +101.1%stock -13.0% next day
- It opened 4.4% lower as soon as trading resumed.
Rose despite an EPS miss (1 of 4)
- Aug 8, 2024EPS missed -382.7%stock +3.3% next day
- It had already fallen 21.1% in the final week before the report, so weak results may have been expected.
- It opened 10.5% higher as soon as trading resumed.
Patterns in estimates and prices, not confirmed causes: how we read them.
Was XFOR's earnings move already priced in?
XFOR's move in the month before each of its last 12 reports, against what it did after.
How the run-up is measured (a move of 5% or more counts as large).
Before vs after each report
Grey: the month before each of the last 12 reports. Green or red: the day after.
Past reports only. How the run-up is measured
Does XFOR hold its opening gap after earnings?
XFOR's opening move after each report and where it closed that day.
In 10 reports XFOR opened at least 1% away from the previous close. It gave back half or more of that gap by the close 1 of 10 times (10%). Gaps up faded 1 of 3; gaps down recovered 0 of 7.
- Nov 4, 2026HeldOpened -5.2%, closed -5.2%
- Aug 6, 2026HeldOpened +2.2%, closed +11.3%
- Mar 17, 2026HeldOpened +5.3%, closed +18.8%
- Nov 5, 2025HeldOpened -6.3%, closed -10.6%
- Aug 8, 2025HeldOpened -1.3%, closed -4.7%
- May 1, 2025HeldOpened -4.4%, closed -13.0%
- Mar 25, 2025HeldOpened -3.7%, closed -12.2%
- Nov 13, 2024HeldOpened -12.5%, closed -53.2%
What the history says
- XFOR has beaten EPS estimates in 7 straight quarters.
- It fell after 4 of its 8 EPS beats (50%): beating estimates has not been enough on its own.
XFOR earnings history
Last 12 reported quarters with the stock's reaction.
Swipe sideways to see every column →
| Report date | Time | EPS est. | EPS actual | Surprise | 1-day move | 3-day move |
|---|---|---|---|---|---|---|
| Nov 4, 2026 | After close | -$0.19 | -$0.16 | +15.8% | -5.25% | — |
| Aug 6, 2026 | After close | -$0.18 | -$0.13 | +27.8% | +11.27% | +2.64% |
| May 6, 2026 | Before open | -$0.20 | -$0.16 | +20.0% | +4.29% | +5.48% |
| Mar 17, 2026 | Before open | -$0.35 | -$0.22 | +37.1% | +18.82% | +17.13% |
| Nov 5, 2025 | Before open | -$0.84 | -$0.69 | +17.9% | -10.58% | -6.55% |
| Aug 8, 2025 | After close | -$4.34 | -$3.47 | +20.0% | -4.70% | +96.64% |
| May 1, 2025 | Before open | -$3.75 | $0.04 | +101.1% | -12.99% | -23.43% |
| Mar 25, 2025 | Before open | -$4.72 | -$6.00 | -27.1% | -12.20% | -8.14% |
| Nov 13, 2024 | Before open | -$5.16 | -$5.40 | -4.7% | -53.21% | -31.76% |
| Aug 8, 2024 | Before open | $0.75 | -$2.12 | -382.7% | +3.33% | +0.79% |
| May 7, 2024 | Before open | -$4.35 | -$7.80 | -79.3% | -9.17% | -11.25% |
| Mar 21, 2024 | Before open | -$4.55 | -$3.00 | +34.1% | +28.43% | +43.14% |
XFOR Earnings FAQ
Answers computed from X4 Pharmaceuticals, Inc's reported history
XFOR has no upcoming report date in the calendar yet. It last reported on Nov 4, 2026; companies usually report every three months.
Over the last 12 quarters with a usable EPS surprise, XFOR beat the consensus estimate 8 times (67%), missed 4 and landed in line 0. It has beaten estimates in each of the last 7 counted quarters.
Across its last 12 quarters with a measured reaction, XFOR moved an average of ±14.5% in the first session after reporting. It closed higher 42% of the time; the largest gain was 28.4% and the largest drop -53.2%.
XFOR fell in the first session after 4 of its last 8 EPS beats (50%). A beat that was already priced in, or weaker guidance, can send a stock lower. In 2 of the 4 of those falls where price data is available, the stock had already risen before the report.
Across its last 12 quarters with price data, XFOR moved an average of +0.5% in the 20 trading sessions before reporting and was higher in 75% of them. After a run-up of 3% or more (8 quarters), it fell the next day 50% of the time, averaging -1.4%. After a drop of 3% or more (3 quarters), it rose the next day 0% of the time, averaging -11.5%. This describes past reports; it is not a forecast.
In 10 reports XFOR opened at least 1% away from the previous close. It gave back half or more of that gap by the close 1 of 10 times (10%), and fully reversed 0 times. A fade means the opening move was partly undone during the first session.
How we calculate these numbers · XFOR: 12 reported quarters, latest Nov 4, 2026. Information only, not investment advice.
Looking for more on XFOR?
Price charts, forecast, fundamentals and risk pages for XFOR are not on Tickzen yet. You can run a full stock analysis now.
Run the XFOR Stock AnalyzerLatest TickZen Insights
AbbVie (ABBV) Q3 2026 Earnings Preview: Will Skyrizi and Rinvoq be able to justify the 20x?By Vishal Jadaun
Alphabet (GOOG) Q3 2026 Earnings Preview: Will Cloud Overtake Capex?By Vishal Jadaun
HSBC Q3 2026 Earnings Preview: Is the $46bn NII Guide Too Low?By Vishal Jadaun